StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen accrued liabilities ($M) ($M)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, FY2025
18,523
Period ended Dec 31, 2025
Change on a year earlier
+5.0%
17,641 in FY2024
History
18 years
Since FY2008
Sources
17
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccrued liabilities ($M) ($M)Year on yearSource
FY2025Dec 31, 202518,523+5.0%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 202417,641+14.9%Form 10-K (filed 2025-02-14) ↗
FY2023Dec 31, 202315,359+22.6%Form 10-K (filed 2024-02-14) ↗
FY2022Dec 31, 202212,524+16.7%Form 10-K (filed 2023-02-09) ↗
FY2021Dec 31, 202110,731+5.8%Form 10-K (filed 2022-02-16) ↗
FY2020Dec 31, 202010,141+19.2%Form 10-K (filed 2021-02-09) ↗
FY2019Dec 31, 20198,511+8.3%Form 10-K (filed 2020-02-12) ↗
FY2018Dec 31, 20187,862+20.7%Form 10-K (filed 2019-02-13) ↗
FY2017Dec 31, 20176,516+10.7%Form 10-K (filed 2018-02-13) ↗
FY2016Dec 31, 20165,884+7.9%Form 10-K (filed 2017-02-14) ↗
FY2015Dec 31, 20155,452-1.1%Form 10-K (filed 2016-02-16) ↗
FY2014Dec 31, 20145,513+18.4%Form 10-K (filed 2016-02-16) ↗
FY2013Dec 31, 20134,655-2.8%Form 10-K (filed 2014-02-24) ↗
FY2012Dec 31, 20124,791-4.7%Form 10-K (filed 2013-02-27) ↗
FY2011Dec 31, 20115,028+49.4%Form 10-K (filed 2012-02-29) ↗
FY2010Dec 31, 20103,366+2.0%Form 10-K (filed 2011-02-25) ↗

Cite this data

StockData. (2026). Amgen Accrued liabilities ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_accrued

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.